The U.S. pharmaceutical water market size surpassed USD 4.75 billion in 2025 and is predicted to reach around USD 10.16 billion by 2035, registering a CAGR of 7.9% from 2026 to 2035. The U.S. Market is mainly influenced by strict regulatory requirements for ultra-pure water, the fast growth of biologics and sterile injectables production, and a rising need for treatments of chronic diseases.

U.S. Pharmaceutical Water Market Statical Scope

The market is essential as it serves as the highly regulated foundation of drug manufacturing, guaranteeing safety and effectiveness in products ranging from vaccines to biologics. It is crucial due to strict FDA regulations, ensuring water quality for injection (WFI), and purification to avoid contamination, which is vital for drug stability. The increasing production of high-quality, sterile, and complex pharmaceuticals, including biologics, vaccines, and injectables, depends entirely on high-purity water. The market meets the growing demand for specialized medicine, allowing pharmaceutical manufacturers to uphold high safety standards in drug formulation. Additionally, it fosters innovation in filtration and water management, balancing the need for large water usage with sustainability requirements.

U.S. Pharmaceutical Water Market, By Type, 2025 (%)

• Water for Injection - The Water for Injection (WFI) segment, with a share of 61%, is dominating in the U.S. market as it represents the highest-purity standard needed for producing sterile injectable drugs, biologics, and vaccines, making it the largest market segment.
• HPLC Grade Water - The HPLC Grade Water segment, with a share of 39%, plays a vital role in the U.S. pharmaceutical market , ensuring precise analytical results and adherence to strict regulatory standards (FDA, USP) during drug formulation, cleaning, and quality testing of pharmaceutical and biological products.

U.S. Pharmaceutical Water Market, By Application, 2025 (%)

• Pharmaceutical & Biotechnology Companies - The pharmaceutical and biotechnology companies segment, with a share of 70%, leads the U.S. market due to the high demand for purified water and Water for Injection (WFI) in the production of biologics, vaccines, and injectables.
• Academics & Research Laboratories - The Academics & Research Laboratories segment, with a share of 30%, is significant in the U.S. pharmaceutical market because of the high-purity water requirements for R&D, drug discovery , and validation in drug development.

Top Companies in the U.S. Pharmaceutical Water Market

• Merck KGaA
• B. Braun Melsungen AG
• Thermo Fisher Scientific, Inc.
• Cytiva (Danaher)
• Fresenius Kabi AG
• Pfizer, Inc.
• CovaChem, LLC
• Intermountain Life Sciences

Segments Covered in the Report

By Type

• HPLC Grade Water
• Water for Injection

By Application

• Pharmaceutical & Biotechnology Companies
• Academics & Research Laboratories